Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-23-014229
Filing Date
2023-04-28
Accepted
2023-04-28 16:44:42
Documents
2
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A blcm10-ka.htm 10-K/A 392633
2 EX-31.2 exhibit312.htm EX-31.2 4659
  Complete submission text file 0001628280-23-014229.txt   398390
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36783 | Film No.: 23867482
SIC: 2834 Pharmaceutical Preparations